EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke

Liyuan Wang iD, Manjun Hao iD, Na Wu, Shuangzhe Wu, Marc Fisher iD, Yunyun Xiong iD

Journal of the American Heart Association · 07.05.2024 · 13 (9)

DOI: 10.1161/jaha.123.031692 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, erschienen am 07.05.2024. Verfasst von Liyuan Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China. Hauptthemen laut MEDLINE: Tenecteplase, Fibrinolytic Agents, Ischemic Stroke, Thrombolytic Therapy. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although intravenous thrombolysis with alteplase remains the primary treatment for acute ischemic stroke, tenecteplase has shown potential advantages over alteplase. Animal studies have demonstrated the favorable pharmacokinetics and pharmacodynamics of tenecteplase. Moreover, it is easier to administer. Clinical trials have demonstrated that tenecteplase is not inferior to alteplase and may even be superior in cases of acute ischemic stroke with large vessel occlusion. Current evidence supports the time and cost benefits of tenecteplase, suggesting that it could potentially replace alteplase as the main option for thrombolytic therapy, especially in patients with large vessel occlusion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TenecteplaseFibrinolytic AgentsIschemic StrokeThrombolytic TherapyTissue Plasminogen ActivatorHumansTreatment OutcomeAnimals

Stichwörter der Autor:innen

alteplaseischemic stroketenecteplasethrombolysis

Substanzen

TenecteplaseFibrinolytic AgentsTissue Plasminogen Activator

Autor:innen und Institutionen

  • Department of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China.
  • Chinese Institute for Brain Research Beijing China.
  • Department of Neurology, Beth Israel Deaconess Medical Center Harvard Medical School Boston MA USA.

ORCID-Profile: Liyuan Wang, Manjun Hao, Marc Fisher, Yunyun Xiong

Zitieren

APA

Wang, L., Hao, M., Wu, N., Wu, S., Fisher, M., & Xiong, Y. (2024). Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke. Journal of the American Heart Association, 13(9). https://doi.org/10.1161/jaha.123.031692

Vancouver

Wang L, Hao M, Wu N, Wu S, Fisher M, Xiong Y. Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke. Journal of the American Heart Association. 2024;13(9). doi:10.1161/jaha.123.031692

BibTeX
@article{Wang2024,
  author = {Wang, Liyuan and Hao, Manjun and Wu, Na and Wu, Shuangzhe and Fisher, Marc and Xiong, Yunyun},
  title = {Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {9},
  doi = {10.1161/jaha.123.031692}
}
Kostenlos starten →